Paolo Pevarello

This inventor holds 49 USPTO granted patents and 11 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in Antitumor Agents. Top assignees: Nerviano Medical Sciences S.r.l., Pharmacia & Upjohn, Farmitalia Carlo Erba S.r.l.. Active years: 1993-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Pevarello. Retrieved from https://idiyas.com/inventor/paolo-pevarello

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 49 (Patent Applications = 11)

% Patents Active = 73.5

CIPO Patents = 6 (Patent Applications = 8)

EPO Patents = 10 (Patent Applications = 27)

Average Co-Inventor Count = 5.4

ph-index = 17

Forward Citations = 819(Granted Patents)

Location History:

Madrid, ES (2008 - 2011)
Bresso, IT (2013 - 2023)
Pavia, IT (1993 - 2024)

Company Filing History:

12 out of 139

Nerviano Medical Sciences S.r.l.

Farmitalia Carlo Erba S.r.l.

Newron Pharmaceuticals S.p.a.

patents

6. 4 out of 26

Pharmacia Italia S.p.a.

patents

7. 3 out of 3

Golgi Neurosciences S.r.l.

patents

8. 3 out of 5,638

The University of Texas System

patents

9. 2 out of 2

Breye Therapeutics Aps

patents

10. 1 out of 4

Centro Nacional De Investigaciones Oncologicas (Cnio)

Pharmacia & Tubjohn Spa

patent

13. 1 out of 523

Pharmacia & Upjohn Company

patents

14. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2026

Loading Chart...

Areas of Expertise:

Antitumor Agents

P2X7 Receptor Antagonists

Kinase Inhibitors

Bicyclic CX3CR1 Agonists

Pyrazolo-Quinazoline Derivatives

Substituted Thiazole

Alpha-Aminoamide Derivatives

Fluorinated Arylalkylaminocarboxamides

Azaindole Derivatives

3(5)-Amino-Pyrazole Derivatives

Substituted Pyrrolo-Pyrazole

Bicyclo-Pyrazoles

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545682 - Heterocyclic derivatives as P2X7 receptor antagonists (2026-02-10),

2. 12258337 - Bicyclic CX3CR1 receptor agonists (2025-03-25),

3. 11958839 - Bicyclic CX3CR1 receptor agonists (2024-04-16),

4. 11623919 - Heterocyclic P2X7 antagonists (2023-04-11),

5. 11597702 - Substituted pyrazoles FFA4/GPR120 receptor agonists (2023-03-07),

6. 11155538 - Bicyclic CX3CR1 receptor agonists (2021-10-26),

7. 10669267 - Substituted N-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide and N-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide derivatives P2X7 receptor antagonists (2020-06-02),

8. 10280176 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2019-05-07),

9. 10167281 - Substituted thiazole or oxazole P2X7 receptor antagonists (2019-01-01),

10. 9718812 - Substituted thiazole or oxazole P2X7 receptor antagonists (2017-08-01),

11. 9637497 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2017-05-02),

12. 9464090 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2016-10-11),

13. 9447029 - Fluorinated arylalkylaminocarboxamide derivatives (2016-09-20),

14. 9012487 - Bicyclo-pyrazoles active as kinase inhibitors (2015-04-21),

15. 8981089 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2015-03-17),

Title: The Innovative Mind of Paolo Pevarello

Introduction: Paolo Pevarello, a talented inventor hailing from Pavia, Italy, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Paolo Pevarello holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Paolo Pevarello has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of inventions. His passion for creating solutions to complex problems has led to the development of cutting-edge technologies that have the potential to revolutionize various industries.

Collaborations: Paolo Pevarello has collaborated with top universities and multinational corporations, fostering a culture of innovation and knowledge-sharing. His ability to work effectively in multidisciplinary teams has resulted in the successful implementation of numerous projects that have garnered international recognition.

Conclusion: In conclusion, Paolo Pevarello stands as a visionary inventor whose relentless pursuit of innovation has left an indelible mark on the world of technology. His passion for creating transformative solutions continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.